Bulletin
Investor Alert

June 7, 2021, 11:44 a.m. EDT

Medical Cannabis Market Overview Highlighting Major Drivers, Size, Share, and Demand Report 2020- 2027

new
Watchlist Relevance
LEARN MORE

Want to see how this story relates to your watchlist?

Just add items to create a watchlist now:

or Cancel Already have a watchlist? Log In

Jun 07, 2021 (Heraldkeepers) -- The Global Medical Cannabis Market research report, released by Emergen Research, gives an extensive study of the industry with the essential data and information relating to the global market. The market evaluations over the forecast years on the basis of an in-depth study of the leading market segments, product type outlook, application continuum, regional overview, and the highly competitive scenario of the market.

Medical cannabis is safe and has less side-effect as compared to other treatment options. It is used to treat nausea and combat negative side-effects, especially among chemotherapy patients, making the whole procedure more tolerable. The product is used with other opioid painkillers, which permits patients to reduce the dosage and frequency of opioids, relieving pain.

To receive a sample of the global Medical Cannabis market report @ https://www.emergenresearch.com/request-sample/174

Key Highlights From The Report

  • In October 2020, MediPharm Labs Corp. signed an exclusive supply agreement with STADA to meet the growing demand for medical cannabis in Germany. STADA wanted to be the go-to partner for generics, which is achieved by the partnership.

  • Inhalation is a preferred medium of administration, as it offers controlled dosage and effective absorption of cannabinoids into the body. This is expected to propel the demand for the market in the coming years.

  • Medical cannabis is used to treat anorexic patients, which resulted from AIDS/HIV. Cannabis stimulates their appetite instead of feeding the patient through tubes. It is more beneficial for the patient's physical and emotional well-being to be fed natural rather than through tubes.

  • North America held the largest market share of 31.1% in 2019, as the product is commonly used to treat patients. Countries in the region are promoting derivatives such as resins, tinctures, oil, and vaporizers among the youth, who are the primary consumers.

  • Key participants include Canopy Growth Corporation, Aphria, Inc., Aurora Cannabis, Maricann Group, Inc., Tilray, Cronos Group, Organigram Holdings, Inc., Vivo Cannabis, Tikun Olam, and Insys Therapeutics, Inc., among others.

Medical Cannabis Market Segmentation:

For the purpose of this report, Emergen Research has segmented into the global Medical Cannabis Market on the basis of product type, application, and route of administration, distribution channel, and region:

  • Product Type Outlook (Revenue, USD Billion; 2017-2027)

  • Application Outlook (Revenue, USD Billion; 2017-2027)

  • Route of Administration Outlook (Revenue, USD Billion; 2017-2027)

  • Distribution Channel Outlook (Revenue, USD Billion; 2017-2027)

Key Regions analyzed in the report include:

  • North America (U.S., Canada)

  • Europe (U.K., Italy, Germany, France, Rest of EU)

  • Asia Pacific (India, Japan, China, South Korea, Australia, Rest of APAC)

  • Latin America (Chile, Brazil, Argentina, Rest of Latin America)

  • Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of MEA)

Request customization of the report @ https://www.emergenresearch.com/request-for-customization/174

Global Medical Cannabis Market Report - Key Takeaways:

  • The latest research report analyzes the changing competitive scenario.

  • The report carries an unbiased perspective towards the global market performance.

  • The study presents an eight-year assessment of the global market and its principal product segments.

1 2
This Story has 0 Comments
Be the first to comment

Story Conversation

Commenting FAQs »

Partner Center

Link to MarketWatch's Slice.